-- Preview Email Newsletter
| U.S. Congressional Tipoffs Involving Maryland Newsletter for 2023-05-09 ( 3 items ) |
|
Cardin, Van Hollen Join Congressional Colleagues in Filing Amicus Brief Urging Reversal of Texas District Court's Ruling on Mifepristone (10)
WASHINGTON, May 9 -- Sen. Benjamin Cardin, D-Maryland, issued the following news release:
This week, U.S. Senators Ben Cardin and Chris Van Hollen (both D-Md.) joined their colleagues in submitting an amicus brief to the U.S. Court of Appeals for the Fifth Circuit in the case of Alliance for Hippocratic Medicine v. FDA, urging the Court to reverse the district court's stay on the FDA's more than 20-year-old approval of mifepristone. In April, the Supreme Court issued a stay of the lower court r more PR
Trone Attends HHS Mental Health Summit and Visits Eastern Shore to Highlight Mental Health Month (10)
SALISBURY, Maryland, May 9 -- Rep. David Trone, D-Maryland, issued the following news release on May 8, 2023:
Last week, Congressman David Trone (D-MD) honored Mental Health Awareness Month and visited the Eastern Shore to discuss progress on combating the opioid epidemic and expanding broadband access.
On Thursday, Trone joined United States Department of Health and Human Services (HHS) Secretary Xavier Becerra for aMental Health Summit. One in five U.S. adults live with a mental illness, and more PR
Van Hollen, Cardin Join Congressional Colleagues in Filing Amicus Brief Urging Reversal of Texas District Court's Ruling on Mifepristone (10)
WASHINGTON, May 9 -- Sen. Chris Van Hollen, D-Maryland, issued the following news release:
This week, U.S. Senators Chris Van Hollen and Ben Cardin (both D-Md.) joined their colleagues in submitting an amicus brief to the U.S. Court of Appeals for the Fifth Circuit in the case of Alliance for Hippocratic Medicine v. FDA, urging the Court to reverse the district court's stay on the FDA's more than 20-year-old approval of mifepristone. In April, the Supreme Court issued a stay of the lower court more PR
|